Skip to content
OpenCapital
Get started

Haemonetics HAE Shares (Diluted)

Shares (Diluted) at other companies

Abbott logo
AbbottABT
1.7B0.0%
TFX
TeleflexTFX
44.3M-3.6%
Boston Scientific logo
Boston ScientificBSX
1.5B+0.1%
Medtronic logo
MedtronicMDT
1.3B-0.1%
LivaNova logo
LivaNovaLIVN
55.9M+2.8%
ICU Medical logo
ICU MedicalICUI
25.2M+2.6%

Other financials

Income statement

See full
Revenue$346.4M+4.8%
Gross profit$198.2M+2.7%
Operating income$67.4M+14.2%
Net income$44.7M+19.3%
EPS (diluted)$0.95+28.4%

Balance sheet

See full
Cash & equivalents$245.4M-20.0%
Total debt$1.3B-0.7%
Total equity$796.3M-3.0%
Total assets$2.4B-2.2%

Cash flow

See full
Operating cash flow$70.9M-39.1%
CapEx$17.7M+12.9%
Free cash flow$53.3M-47.2%

Valuation

See full
Market cap$3.31B-18.0%

Profitability

See full
Gross margin59%+4.0pp
Operating margin19%+5.9pp
Net margin13.3%+3.8pp
FCF margin19.5%+9.1pp

Returns & leverage

See full
Return on equity19.3%+5.2pp
Debt / equity1.6×0.0×
Current ratio3×+1.3×

Where this comes from

Reported directly by Haemonetics in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →

Ask your AI about Haemonetics's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Haemonetics's shares (diluted)?
Haemonetics (HAE) reported shares (diluted) of 47.4M in Q1 2026.
How has Haemonetics's shares (diluted) changed year-over-year?
Haemonetics's shares (diluted) decreased by 6.7% year-over-year, from 50.7M to 47.4M.
What is the long-term trend for Haemonetics's shares (diluted)?
Over 4 years (2022 to 2026), Haemonetics's shares (diluted) has grown at a -1.8% compound annual growth rate (CAGR), from 205.1M to 190.4M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.